1,316
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Pan-precancer and cancer DNA methylation profiles revealed significant tissue specificity of interrupted biological processes in tumorigenesis

, , , , , , , , , & ORCID Icon show all
Article: 2231222 | Received 03 Mar 2023, Accepted 21 Jun 2023, Published online: 02 Jul 2023

References

  • Koch A, Joosten SC, Feng Z, et al. Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol. 2018;15(7):459–17. doi: 10.1038/s41571-018-0004-4
  • Gao Q, Zeng Q, Wang Z, et al. Circulating cell-free DNA for cancer early detection. The Innovation. 2022;3(4):100259. doi: 10.1016/j.xinn.2022.100259
  • Ehrlich M, Gama-Sosa MA, Huang LH, et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucl Acids Res. 1982;10(8):2709–2721. doi: 10.1093/nar/10.8.2709
  • Bird A, Taggart M, Frommer M, et al. A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell. 1985;40:91–99. doi: 10.1016/0092-8674(85)90312-5
  • Mohn F, Weber M, Rebhan M, et al. Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol Cell. 2008;30(6):755–766. doi: 10.1016/j.molcel.2008.05.007
  • Nawy T. Dynamics of DNA demethylation. Nat Methods. 2013;10(6):466. doi: 10.1038/nmeth.2506
  • Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell. 2011;146(6):866–872. doi: 10.1016/j.cell.2011.08.042
  • Locke WJ, Guanzon D, Ma C, et al. DNA methylation cancer biomarkers: translation to the clinic. Front Genet. 2019;10:1150. doi: 10.3389/fgene.2019.01150
  • Paz MF, Wei S, Cigudosa JC, et al. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Hum Mol Genet. 2003;12(17):2209–2219. doi: 10.1093/hmg/ddg226
  • Jain PK. Epigenetics: the role of methylation in the mechanism of action of tumor suppressor genes. Ann N Y Acad Sci. 2003;983(1):71–83. doi: 10.1111/j.1749-6632.2003.tb05963.x
  • Cheah MS, Wallace CD, Hoffman RM. Hypomethylation of DNA in human cancer cells: a site-specific change in the c-myc oncogene. J Natl Cancer Inst. 1984;73:1057–1065.
  • Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 1997;13(8):335–340. doi: 10.1016/S0168-9525(97)01181-5
  • Ball MP, Li JB, Gao Y, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol. 2009;27(4):361–368. doi: 10.1038/nbt.1533
  • Oberdoerffer S. A conserved role for intragenic DNA methylation in alternative pre-mRNA splicing. Transcription. 2012;3(3):106–109. doi: 10.4161/trns.19816
  • Lorincz MC, Dickerson DR, Schmitt M, et al. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol. 2004;11(11):1068–1075. doi: 10.1038/nsmb840
  • Zlotorynski E. Epigenetics: dNA methylation prevents intragenic transcription. Nat Rev Mol Cell Biol. 2017;18(4):212–213. doi: 10.1038/nrm.2017.18
  • Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010;466(7303):253–257. doi: 10.1038/nature09165
  • McGuire MH, Herbrich SM, Dasari SK, et al. Pan-cancer genomic analysis links 3‘UTR DNA methylation with increased gene expression in T cells. EBioMedicine. 2019;43:127–137. doi: 10.1016/j.ebiom.2019.04.045
  • Wang C, Chen L, Yang Y, et al. Identification of potential blood biomarkers for Parkinson’s disease by gene expression and DNA methylation data integration analysis. Clin Epigenetics. 2019;11(1):24. doi: 10.1186/s13148-019-0621-5
  • Pan X, Zhang C, Wang J, et al. Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma. Brief Bioinform. 2022;23(1):23. doi: 10.1093/bib/bbab481
  • Li M, Zou D, Li Z, et al. EWAS Atlas: a curated knowledgebase of epigenome-wide association studies. Nucleic Acids Res. 2019;47:D983–d8. doi: 10.1093/nar/gky1027
  • Chen Y, Breeze CE, Zhen S, et al. Tissue-independent and tissue-specific patterns of DNA methylation alteration in cancer. Epigenet Chromatin. 2016;9(1):10. doi: 10.1186/s13072-016-0058-4
  • Danilova L, Wrangle J, Herman JG, et al. DNA-methylation for the detection and distinction of 19 human malignancies. Epigenetics. 2022;17(2):191–201. doi: 10.1080/15592294.2021.1890885
  • Kang S, Li Q, Chen Q, et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18(1):53. doi: 10.1186/s13059-017-1191-5
  • Xia D, Leon AJ, Cabanero M, et al. Minimalist approaches to cancer tissue-of-origin classification by DNA methylation. Mod Pathol. 2020;33:1874–1888. doi: 10.1038/s41379-020-0547-7
  • Rideout WM 3rd, Coetzee GA, Olumi AF, et al. 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science. 1990;249(4974):1288–1290. doi: 10.1126/science.1697983
  • Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis. 2000;21(3):461–467. doi: 10.1093/carcin/21.3.461
  • Russo G, Landi R, Pezone A, et al. DNA damage and repair modify DNA methylation and chromatin domain of the targeted locus: mechanism of allele methylation polymorphism. Sci Rep. 2016;6(1):33222. doi: 10.1038/srep33222
  • Russo G, Tramontano A, Iodice I, et al. Epigenome chaos: stochastic and deterministic DNA methylation events drive cancer evolution. Cancers (Basel). 2021;13(8):1800. doi: 10.3390/cancers13081800
  • Fan J, Li J, Guo S, et al. Genome-wide DNA methylation profiles of low- and high-grade adenoma reveals potential biomarkers for early detection of colorectal carcinoma. Clin Epigenetics. 2020;12(1):56. doi: 10.1186/s13148-020-00851-3
  • Tian Y, Morris TJ, Webster AP, et al. ChAMP: updated methylation analysis pipeline for Illumina BeadChips. Bioinformatics. 2017;33(24):3982–3984. doi: 10.1093/bioinformatics/btx513
  • Heger A, Webber C, Goodson M, et al. GAT: a simulation framework for testing the association of genomic intervals. Bioinformatics. 2013;29(16):2046–2048. doi: 10.1093/bioinformatics/btt343
  • Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. The Innovation. 2021;2:100141. doi: 10.1016/j.xinn.2021.100141
  • Sondka Z, Bamford S, Cole CG, et al. The COSMIC cancer gene census: describing genetic dysfunction across all human cancers. Nat Rev Cancer. 2018;18(11):696–705. doi: 10.1038/s41568-018-0060-1
  • Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556–W60. doi: 10.1093/nar/gkz430
  • Usui G, Matsusaka K, Mano Y, et al. DNA methylation and genetic aberrations in gastric cancer. Digestion. 2021;102(1):25–32. doi: 10.1159/000511243
  • El-Zein M, Cheishvili D, Gotlieb W, et al. EL, group Ms. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia. Int J Cancer. 2020;147:1264–1274. doi: 10.1002/ijc.32880
  • García DA, Abba MC, Briceño I, et al. DNA methylation pattern in high-grade cervical intraepithelial neoplasia and cancer revealed by genomewide methylation analysis of cervical DNA. Integr Mol Med. 2017;4:4. doi: 10.15761/IMM.1000309
  • Verlaat W, Snijders PJF, Novianti PW, et al. Genome-wide DNA methylation profiling reveals methylation markers associated with 3q gain for detection of cervical precancer and cancer. Clin Cancer Res. 2017;23(14):3813–3822. doi: 10.1158/1078-0432.CCR-16-2641
  • Becht E, Giraldo NA, Lacroix L, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Bio. 2016;17(1):218. doi: 10.1186/s13059-016-1070-5
  • Liu G, Liu Z, Sun X, et al. Pan-cancer genome-wide DNA methylation analyses revealed that hypermethylation influences 3D architecture and gene expression dysregulation in HOXA locus during carcinogenesis of cancers. Front Cell Dev Biol. 2021;9:649168. doi: 10.3389/fcell.2021.649168
  • Ding W, Chen G, Shi T. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis. Epigenetics. 2019;14(1):67–80. doi: 10.1080/15592294.2019.1568178
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013
  • Preissl S, Gaulton KJ, Ren B. Characterizing cis-regulatory elements using single-cell epigenomics. Nat Rev Genet. 2022;24(1):21–43. doi: 10.1038/s41576-022-00509-1
  • Wang Q, Xiong F, Wu G, et al. Gene body methylation in cancer: molecular mechanisms and clinical applications. Clin Epigenetics. 2022;14(1):154. doi: 10.1186/s13148-022-01382-9
  • Zhao Y, Guo S, Sun J, et al. Methylcap-seq reveals novel DNA methylation markers for the diagnosis and recurrence prediction of bladder cancer in a Chinese population. PLoS One. 2012;7(4):e35175. doi: 10.1371/journal.pone.0035175
  • Singh A, Gupta S, Badarukhiya JA, et al. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer. Int J Cancer. 2020;147(6):1740–1752. doi: 10.1002/ijc.32984
  • Nekrasov KA, Vikarchuk MV, Rudenko EE, et al. 6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage. Oncol Lett. 2019;18:6917–6925. doi: 10.3892/ol.2019.11015
  • Nawaz I, Qiu X, Wu H, et al. Development of a multiplex methylation specific PCR suitable for (early) detection of non-small cell lung cancer. Epigenetics. 2014;9(8):1138–1148. doi: 10.4161/epi.29499
  • Li P, Liu S, Du L, et al. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer. Clin Epigenetics. 2022;14(1):118. doi: 10.1186/s13148-022-01337-0
  • Li M, Zhang C, Zhou L, et al. Identification and validation of novel DNA methylation markers for early diagnosis of lung adenocarcinoma. Mol Oncol. 2020;14(11):2744–2758. doi: 10.1002/1878-0261.12767
  • Khan MA, Massey S, Ahmad I, et al. FOXO1 gene downregulation and promoter methylation exhibits significant correlation with clinical parameters in Indian breast cancer patients. Front Genet. 2022;13:842943. doi: 10.3389/fgene.2022.842943
  • Ibrahim J, Peeters M, Van Camp G, et al. Methylation biomarkers for early cancer detection and diagnosis: current and future perspectives. Eur J Cancer. 2023;178:91–113. doi: 10.1016/j.ejca.2022.10.015
  • Cassinotti E, Melson J, Liggett T, et al. DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps. Int J Cancer. 2012;131(5):1153–1157. doi: 10.1002/ijc.26484
  • Wang B, Qi X, Liu J, et al. MYH9 promotes growth and metastasis via activation of MAPK/AKT signaling in colorectal cancer. J Cancer. 2019;10(4):874–884. doi: 10.7150/jca.27635
  • Liliac L, Carcangiu ML, Canevari S, et al. The value of PAX8 and WT1 molecules in ovarian cancer diagnosis. Rom J Morphol Embryol. 2013;54:17–27.